|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.65 TWD | +0.48% |
|
-2.62% | +43.86% |
DR.Chip Biotechnology Incorporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 19.73 million compared to TWD 28.82 million a year ago. Net loss was TWD 9.54 million compared to TWD 3.94 million a year ago.
Basic loss per share from continuing operations was TWD 0.45 compared to TWD 0.21 a year ago. Diluted loss per share from continuing operations was TWD 0.45 compared to TWD 0.21 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +43.86% | 38.51M | |
| +73.46% | 12.41B | |
| -15.61% | 8.23B | |
| +3.88% | 6.46B | |
| +14.69% | 5.5B | |
| -5.53% | 5.33B | |
| +42.58% | 5.1B | |
| -32.61% | 2.54B | |
| +10.80% | 1.99B | |
| -0.74% | 1.99B |
NEOCORE TECHNOLOGY CO., LTD. 